The pathophysiology and mechanism of Breath-Holding Spells (BHS) remain controversial, and the relationship between BHS and anemia has not been clarified, although iron supplementation appears to be effective in many patients. We aimed to assess the probable relation of iron level with initiation of these spells in children.
Introduction
"Possibly the earliest report of Breath-Holding Spells (BHS) was published in 1737 by Nicolas Culpepper" (1) (2) (3) (4) .
Episodes of BHS are usually accrued in children without any underlying diseases, during expiration.
These attacks are scary for parents because they are similar to some life-threatening diseases. About 60% of affected children have the cyanotic form of BHS, about 20% of affected children have the pallid form, and additional 20% have both types of breath holding spells. The family history is 20%-30% positive in these patients. Pathophysiology and mechanism of BHS remain controversial (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
Iron deficiency anemia is frequently seen in infants (16, 17) . Iron is very important for neurological functioning, including neurotransmitters, myelin formation, and brain energy metabolism (18) (19) (20) (21) (22) (23) . As iron is a very important factor for proper neurological functions, it may have an important role in initiation of BHS. Iron supplements appear to be effective in many BHS patients (24) (25) (26) (27) .
We aimed to assess the probable relation of iron level with initiation of these spells in children. We defined iron deficiency anemia as follows: Hb less than 10.5 g% (for 6 months to 2 yr old cases), Hct<33%, MCV less than 70 fl, MCH less than 23 pg, MCHC less than 30 g/%, RBC<3.7, and serum iron concentration less than 40 µg/dl (for patients younger than 12 months old) and greater than 50 µg/dl (for cases older than 12 months old), PF less than 7 µg/I, and TIBC greater than 430 mcg/dl. We prescribed oral ferrous sulfate solution 6 mg/ kg/d, 3 times daily, for all of cases, regardless of their iron levels. We evaluated the clinical condition of the patient with 3 months follow up; their response to treatment defined as follows: "complete", the attacks disappeared completely; "partial", >50% reduction in the number of attacks; "weak", 10%- Patient's iron level was shown in Table 1 . Simple spells were shown significantly higher mean of Hb in comparison with severe spells (P= 0.008); also increased number of spells per month significantly decreased the mean of Hb (P= 0.007).
Materials & Methods
Results of iron therapy in children with BHS are detailed in Table 2 . Overall, 32 patients (76.19%) had complete control of spells, 7 patients (16.66%) partial, 2 cases (4.76%) weak, and 1 child (2.38%) no response after iron therapy. 
Discussion
The present study designed to assess the probable relation of iron level with BHS in children, and findings revealed that iron deficiency plays an important role on initiation of these spells. Results of this study had some similarities with other studies in this field, as well as some differences.
Linder in a prospective study on 697 patients reported mild BHS in 4.7% and severe BHS in 1.7% of cases (5), consistent with data presented in the current report.
Positive family history was reported in 20%-30% of BHS patients; genetic factors may play an important role in this disease, with a low-penetrance autosomal dominant factor (28) . Although about 50% positive family history reported in some studies (24) ; but some other studies failed to demonstrate positive family history in the BHS patients (29) . We revealed 33.33% positive family history in our patients, confirmed the results of the first studies.
Multiple spells per week reported in majority of patients; about one-third of cases will experience more than one spell per day (30) , similar to our cases.
Cyanotic spells were seen in 54% of cases, pallid in 22%, both types in 12%, and not classifiable in 7% of patients (31, 32) . This is different from our cases, as the cyanotic: pallid: mixed ratio in our patients has emerged as 35:4:3.
Iron deficiency anemia is common worldwide, especially in children living in developing countries (21, 33 Iron deficiency anemia is frequently seen in BHS patients, and iron therapy may have a role in its treatment ( Table 3 ). Holowach et al first described the association between BHS and anemia (26) .
The causative mechanism of iron deficiency in BHS is not fully understood, probably it plays a role through neurotransmitters, enzymes, and catecholamine metabolism (31) . Some other studies suggested the role of reduced oxygen availability to CNS, because of adverse effects of anemia on oxygen uptake in the lungs (24) , and the probable role of erythropoietin, nitric oxide and interleukin 1 (25) . Our study revealed the important role of iron in the treatment of BHS because the mean frequency of spells was significantly higher before iron therapy (P<0.0001); and severity of spells significantly decreased after therapy (P<0.001).
We observed complete control of BHS in 76.19% of our cases, after iron therapy. In our cases, simple spells are shown significantly higher mean of Hb in comparison with severe cases; Mean Hb level was significantly lower when number of spells per month increased.
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